Cipla (CIPLA) Weekly Analysis
Price & Volume
The stock price rose by 0.92% during the week, marking a positive trend. This upward movement occurred alongside a 2.45% price range throughout the week. Investors showed interest with a high average delivery percentage of 64.33%. The stock is currently trading below its 50-day and 200-day moving averages.
Technicals
The stock closed at 1240.8 this week, reflecting a 0.92% increase. Moving Averages (MAs), which represent the average price over a set period to smooth out fluctuations, show the 20-week and 50-week averages are both sloping downward. Momentum indicators, such as the RSI (Relative Strength Index) which measures the speed and change of price movements, rose to 46.8. The MACD (Moving Average Convergence Divergence), which tracks the relationship between two moving averages, shows a positive histogram of 6.38. Volatility, measured by Bollinger Band width, contracted to 7.42%, indicating a decrease in price range variance.
Fundamentals
Cipla has demonstrated consistent long-term growth, with revenue recording a 3-year CAGR of 8.2% (the average annual growth rate over three years). Profitability has expanded significantly, as evidenced by a net profit 3-year CAGR of 27.4% and a TTM net profit margin of 16.0% (the percentage of revenue remaining as profit after all expenses). The company maintains a strong financial position with a net debt-to-EBITDA ratio of 0.1 (a measure of how many years it would take to pay off debt using earnings before interest, taxes, depreciation, and amortization). Recent performance shows a net profit of ₹5,269 in Mar 2025, reflecting a 26.8% YoY increase, highlighting strong operational efficiency and a robust balance sheet.
News
On April 16, 2026, Cipla supported the Investor Education and Protection Fund Authority’s 'Saksham Niveshak' initiative by issuing formal notices to its shareholders. Subsequently, on April 17, 2026, the company officially scheduled its Q4FY26 earnings conference call for May 13, 2026, to discuss its financial performance. Also on April 17, 2026, the equity research firm MarketsMOJO assigned a 'Sell' rating to Cipla Ltd. These developments marked the primary corporate activities for the company during the week ending April 19, 2026.
Events
The USFDA concluded a routine cGMP and pre-approval inspection at Cipla's Goa manufacturing facility, issuing two Form 483 observations. The company has stated it will work to address these observations within the required timeframe.
Cipla Limited has scheduled an earnings conference call for May 13, 2026, to discuss its audited financial results for the quarter ended March 31, 2026.
Cipla Ltd. has published newspaper notices regarding the 'Saksham Niveshak' campaign, an initiative by the Investor Education and Protection Fund Authority (IEPFA) to assist shareholders with dividend claims and KYC updates. This disclosure is part of the company's compliance with SEBI regulations to ensure investor awareness.
Cipla Limited has submitted the compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 31st March 2026, confirming the verification and dematerialization of share certificates by its registrar, KFin Technologies Limited.
Cipla Limited has scheduled a board meeting for 13th May 2026 to approve its audited financial results for the year ended 31st March 2026 and consider a potential final dividend recommendation.
Cipla Limited has scheduled an earnings conference call for May 13, 2026, to discuss its audited financial results for the quarter ended March 31, 2026.
Cipla Ltd. has published newspaper notices regarding the 'Saksham Niveshak' campaign, an initiative by the Investor Education and Protection Fund Authority (IEPFA) to assist shareholders with dividend claims and KYC updates. This disclosure is part of the company's compliance with SEBI regulations to ensure investor awareness.
Cipla Limited has submitted the compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 31st March 2026, confirming the verification and dematerialization of share certificates by its registrar, KFin Technologies Limited.
Cipla Limited has scheduled a board meeting for 13th May 2026 to approve its audited financial results for the year ended 31st March 2026 and consider a potential final dividend recommendation.
Weekly Snapshot
Highlights
- The stock price increased by 0.92% this week, marking two consecutive weeks of gains.
- Technical indicators show a recent bullish crossover in the MACD (Moving Average Convergence Divergence, which tracks the relationship between two moving averages).
- The USFDA completed an inspection at the company's Goa manufacturing facility and issued two Form 483 observations.
- Cipla scheduled an earnings conference call for May 13, 2026, to discuss financial results for the quarter ended March 31, 2026.
- The equity research firm MarketsMOJO assigned a Sell rating to the company on April 17, 2026.
What This Means
Cipla experienced a positive week in terms of price movement, recording a 0.92% gain and maintaining a two-week winning streak. Technical indicators suggest a shift in momentum, with the MACD showing a bullish crossover and the RSI (Relative Strength Index, which measures the speed and change of price movements) rising to 46.8. Despite these market signals, the stock remains below its 50-day and 200-day moving averages. Corporate activity included the receipt of two Form 483 observations from the USFDA regarding the Goa facility and the scheduling of an upcoming earnings call. Additionally, the company participated in an investor awareness campaign and received a Sell rating from a research firm.
Latest Quarter Info
In the quarter ending December 2025, the company reported revenue of 7,074, reflecting a modest year-over-year increase of 0.01% but a sequential decline of 6.79%. Operating profitability remained stable at an 18% margin, supported by 1,255 in operating profit against 5,819 in expenses. However, bottom-line performance faced significant headwinds, with net profit falling to 674. This represents a sharp contraction of 50.18% quarter-over-quarter and 57.21% year-over-year, largely driven by the impact of negative other income, depreciation costs, and a 24% effective tax rate. While the operating margin demonstrates operational discipline, the substantial divergence between top-line stability and bottom-line erosion highlights increased pressure from non-operating items and tax obligations during this period.